07 Jun 2024
// PRESS RELEASE
03 Jun 2024
// PRESS RELEASE
03 Jun 2024
// PRESS RELEASE
Latest Content by PharmaCompass
Shandong Loncom is an R&D-focused manufacturer of Anti-cancer APIs.
About
CPHI Middle eastCPHI Middle east
Industry Trade Show
Not Confirmed
10-12 December, 2024
Medlab Asia & Asia Hea...Medlab Asia & Asia Health
Industry Trade Show
Not Confirmed
24 November-17 July, 2025
Health 2.0 ConferenceHealth 2.0 Conference
Industry Trade Show
Not Confirmed
02-04 December, 2024
CONTACT DETAILS
Events
Webinars & Exhibitions
Severity: Warning
Message: Undefined variable $tile1
Filename: tabs/exhibitions.php
Line Number: 43
Backtrace:
File: /var/www/html/application/views/include/party/inc/tabs/exhibitions.php
Line: 43
Function: _error_handler
File: /var/www/html/application/models/CmnPec.php
Line: 1625
Function: view
File: /var/www/html/application/views/include/party/query.php
Line: 575
Function: create
File: /var/www/html/application/views/include/party/indexNew.php
Line: 70
Function: include
File: /var/www/html/application/views/commonNew.php
Line: 445
Function: include
File: /var/www/html/application/controllers/PharmaServices.php
Line: 4651
Function: view
File: /var/www/html/index.php
Line: 224
Function: require_once
CPHI Middle eastCPHI Middle east
Industry Trade Show
Not Confirmed
10-12 December, 2024
Medlab Asia & Asia Hea...Medlab Asia & Asia Health
Industry Trade Show
Not Confirmed
24 November-17 July, 2025
Health 2.0 ConferenceHealth 2.0 Conference
Industry Trade Show
Not Confirmed
02-04 December, 2024
CORPORATE CONTENT #SupplierSpotlight
07 Jun 2024
// PRESS RELEASE
https://www.loncompharm.com/Darolutamide-A-Promising-Advancement-in-Prostate-Cancer-Treatment-id46480776.html
03 Jun 2024
// PRESS RELEASE
https://www.loncompharm.com/Shandong-Loncom-will-be-participate-in-the-CPHI-China-Expo-id47767776.html
03 Jun 2024
// PRESS RELEASE
https://www.loncompharm.com/Ilaprazole-A-New-Contender-in-the-Fight-Against-Gastroesophageal-Conditions-id46767776.html
18 Jan 2024
// PRESS RELEASE
https://www.loncompharm.com/Niraparib-Tosylate-A-Promising-Treatment-for-Ovarian-Cancer-id62251697.html
17 Jan 2024
// PRESS RELEASE
https://www.loncompharm.com/Unveiling-the-Power-of-Levosimendan-A-Breakthrough-in-Heart-Failure-Treatment-id62896697.html
20 Sep 2023
// PRESS RELEASE
https://www.loncompharm.com/Shandong-Loncom-Pharmaceutical-Co-Ltd-holds-Its-ninth-anniversary-flag-raising-ceremony-id65538217.html
Certificate Number : R0-CEP 2021-451 - Rev 01
Issue Date : 2023-05-16
Type : Chemical
Substance Number : 2992
Status : Valid